Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[09/10/2020 | 20:04]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ekk7omKjJ-2FaMf9bCAuY3e7GvtsmilA7Als95ZrN3XwbDMNyVIaWGO=
aK0f7LeVZs4C-2BUAfuYSwrpCfd5ublydbWIIgns_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wYwYCZqVZ11WYWS2P0-2FTyN7hRrIwtEbFBrZCEcYZStbWTWSsU27hhzrF4PStInMaexIqdqp=
EejJyj-2F68JH6mkYd7OrhemGugq0ezheZK-2BRXvSgp7gZD4ampir5n34j2KIM-2FeUrvWE7o6=
d-2BPcwCovByy1K8jc-2B-2BKDbxgWAztzxDkBVSR2So07wKBbGerOPH-2BBl4llI-2Fm55Q0GP=
U6-2BI25TJz3wwCfAAcJJNjdgJqozyjKgi0BQr3t7MyIifFGa9uLLto-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 9 October 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulat=
ed information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =
=E2=80=9CCompany) (Euronext Brussels: UCB) announces that on 5 October 2020=
, in accordance with the vesting rules under its LTI plans, it has delivere=
d for free a total of 896 UCB shares OTC to 2 members of the personnel of t=
he Company and its subsidiaries. The highest independent bid price on Euron=
ext Brussels on 5 October 2020 was =E2=82=AC 99.50.

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3D91zA_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYwYCZqVZ11WYWS2P0-2=
FTyN7hRrIwtEbFBrZCEcYZStbWTWSsU27hhzrF4PStInMaexIqdqpEejJyj-2F68JH6mkYd7Orh=
emGugq0ezheZK-2BRXvckidPnr-2BDbXokDyRMBc4Gv5DIWpkunJPpv17zjZp5o3AE3ORibSnFw=
y1aYFuSENB1ik8039S-2F7ZSR9Zam0svMI6rWSkReClV7oFtoUdUrP3Pjnn00FO59Ae-2BnNmaK=
-2Bh6mXx7MsQAtsGrx9HMmtzaoY-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0
=C2=A0=C2=A0 =C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
=C2=A0
GenericFile
201009 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekk7omKjJ-2=
FaMf9bCAuY3e7Gfp61NSebE59eUJ87vAEo5qc66Af8IuT1EYQfBo39BqI-3DCjyz_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1wYwYCZqVZ11WYWS2P0-2FTyN7hRrIwtEbFBrZCEcYZStbWTWS=
sU27hhzrF4PStInMaexIqdqpEejJyj-2F68JH6mkYd7OrhemGugq0ezheZK-2BRXvXyBveiugAb=
UjwEowKqD9ibUE6-2BXyeKj4qoXpOLVI-2BSIJJQfONcxCQzvbcHR6AM-2Fov1svb8lFcS1zDPA=
aMZhQEFVBEtGbrrLNMLhTgD7ChiuXqj-2B-2FHRr2TnQ0aEPQ6FmSfOzkBK8T-2FGLbN6DlPEuM=
lU-3D GenericFile
201009 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekk7omKjJ-2FaMf9bCAuY=
3e7Gyof-2BKKaWJtNWhINDhDloRB-2FniVNk-2B9EBvZuC2XajrHM-3DlMi4_xDPID0vOuylFAU=
8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO=
eoCOG9ekocVj-2F2X9c9g1wYwYCZqVZ11WYWS2P0-2FTyN7hRrIwtEbFBrZCEcYZStbWTWSsU27=
hhzrF4PStInMaexIqdqpEejJyj-2F68JH6mkYd7OrhemGugq0ezheZK-2BRXvaHmQWyS0xQh3WD=
zZNsL5Ll7EXqpYmgNxFgdihM5G2TSQ4Dj3yhRyqYYzUGKbCVldWSuronvM8tmtzda3whzOyEunj=
EMGASWFyFBm4ox7v7PBhVSMxS08icq3dF0ICFAngu-2Bxf8Nl-2Bhradju-2BUm2CHI-3D Gene=
ricFile
201009 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekk7omKjJ-2Fa=
Mf9bCAuY3e7GpKKCiDJXVEvWFTer743NfqalQ9mPJoIJkc-2BvcWWgPZA-3DKnY6_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1wYwYCZqVZ11WYWS2P0-2FTyN7hRrIwtEbFBrZCEcYZStbWTWS=
sU27hhzrF4PStInMaexIqdqpEejJyj-2F68JH6mkYd7OrhemGugq0ezheZK-2BRXvd4octVdeTP=
Fbl5y8rRoIhlQYvknkvSOjZS9NpTxIQp-2FwvBdqZRWDzZe-2BkudTyWsWe0PVLLgH2h-2BZdlC=
0GnfJjTtTxqfEmEgjEs-2BAu6LyeI2Em-2FO7npnmuzing5zcgSPOLVSUHvKkD1UuAlrZO1JNGQ=
-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXzbD2j1FKFOmU08b2o-2BV8NeFKi7Crz=
qg0G5s192u9UiSef9eaeBsVaZ490SrlxA21ezJ5C-2BGEyzLc96Rcn-2FBTvvGRSQQrsk61zYMb=
FSoVDyE-3DBBFL_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0Kx=
vPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYwYCZqVZ11WYWS2P0-2FTyN=
7hRrIwtEbFBrZCEcYZStbWTWSsU27hhzrF4PStInMaexIqdqpEejJyj-2F68JH6mkYd7OrhemGu=
gq0ezheZK-2BRXvV8EvvvB-2BXUbhspjOkS82YBMJshOHdmV1plSAeoWLAXpYoIIRkjoDQVSYoN=
MC1a9tI-2B-2Fs7aDGchz083Ct78HN0NvryNYWAS5SXJAqpY8fo-2F5IDXyh4gSSz-2Fyqx8EHx=
i3hefcr7Z1Yi2CIlV-2F7cgroAU-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=